- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00529295
Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at Term
September 13, 2007 updated by: China Medical University Hospital
The purpose of this study was to estimate the safety and efficacy of titrated oral misoprostol compared with vaginal route for labor induction at term.
Study Overview
Detailed Description
Oral misoprostol absorption is more rapid and possible more predictable, with a peak serum concentration following oral administration of 34 minutes and a half-life of 20-40 minutes.
Peak serum concentration for vaginal administration is 60-80 minutes, this level being sustained for up to four hours.
Although the direct local effect of vaginal administration on cervical ripening may be advantageous, the shorter half-life of oral delivery may be beneficial in the event of uterine hyperstimulation.In order to avoid uterine hyperstimulation, it appears reasonable to suggest that oral misoprostol should be administered in small, frequent doses, titrated against the uterine response.
Study Type
Interventional
Enrollment (Actual)
220
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Yun Lin, Taiwan, 651
- China Medical University Beigang Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- 34 to 42 weeks of gestation
- live singleton
- Bishop score < or = 6
- reassuring fetal heart beat pattern
Exclusion Criteria:
- nonreassuring fetal heart beat pattern
- parity ovr five
- any contraindication to labor and/or vaginal delivery
- uterine scar
- suspected placental abruption with abnormal FHR pattern
- vaginal bleeding other than "bloody show"
- cervical dilatation of > or = 4 cm
- uterine contractions > or = 3 in 10 minutes
- significant maternal cardiac, renal or hepatic disease
- hypersensitivity to misoprostol or prostaglandin analogs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Titrated oral misoprostol
|
Titrated oral misoprostol: one tablet of 200 microgram was dissolved in water 200 ml, and 20 ml P.O. per one hour for 4 doses, then titrated against uterine response; Vaginal misoprostol: 25 microgram per vagina
|
Active Comparator: 2
Vaginal misoprostol
|
Titrated oral misoprostol: one tablet of 200 microgram was dissolved in water 200 ml, and 20 ml P.O. per one hour for 4 doses, then titrated against uterine response; Vaginal misoprostol: 25 microgram per vagina
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The interval from the first misoprostol dose to vaginal delivery and the percentage of women who delivered infants vaginally within 12 and 24 hours of induction. The incidence of tachysystole, hypertonus, uterine hyperstimulation and neonatal outcomes.
Time Frame: within the first week after delivery
|
within the first week after delivery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total dosage of misoprostol and the rate of women given oxytocin, cesarean section and induction failure.
Time Frame: The days during induction
|
The days during induction
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Shi-Yann Cheng, M.D., Chinal Medical University Beigang Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kerr RS, Kumar N, Williams MJ, Cuthbert A, Aflaifel N, Haas DM, Weeks AD. Low-dose oral misoprostol for induction of labour. Cochrane Database Syst Rev. 2021 Jun 22;6(6):CD014484. doi: 10.1002/14651858.CD014484.
- Hofmeyr GJ, Alfirevic Z, Matonhodze B, Brocklehurst P, Campbell E, Nikodem VC. Titrated oral misoprostol solution for induction of labour: a multi-centre, randomised trial. BJOG. 2001 Sep;108(9):952-9. doi: 10.1111/j.1471-0528.2001.00231.x.
- Cheng SY, Ming H, Lee JC. Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial. Obstet Gynecol. 2008 Jan;111(1):119-25. doi: 10.1097/01.AOG.0000297313.68644.71.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2005
Study Completion (Actual)
March 1, 2007
Study Registration Dates
First Submitted
September 13, 2007
First Submitted That Met QC Criteria
September 13, 2007
First Posted (Estimate)
September 14, 2007
Study Record Updates
Last Update Posted (Estimate)
September 14, 2007
Last Update Submitted That Met QC Criteria
September 13, 2007
Last Verified
September 1, 2006
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DMR95-IRB-116
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Induction
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Northwestern UniversityCompletedLabor InductionUnited States
-
Sorlandet Hospital HFCompleted
-
Mednax Center for Research, Education, Quality...Completed
-
Kanuni Sultan Suleyman Training and Research HospitalUnknown
-
University of ArizonaUnknownLabor InductionUnited States
-
Far Eastern Memorial HospitalCompleted
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
Hadassah Medical OrganizationUnknown
-
Rambam Health Care CampusNot yet recruitingInduction of Labor
Clinical Trials on misoprostol
-
Aljazeera HospitalKasr El Aini HospitalUnknown
-
Hospital de Clinicas de Porto AlegreCompletedMiscarriage in First TrimesterBrazil
-
Cairo UniversityCompleted
-
Ferring PharmaceuticalsCompletedCervical Ripening | Labor InductionUnited Kingdom
-
Medstar Health Research InstituteSociety of Family PlanningCompletedSecond Trimester AbortionsUnited States
-
Karolinska InstitutetCompletedFirst Trimester Pregnancy | Surgical Termination of PregnancySweden
-
CHA UniversityCompleted
-
Wenzhou Medical UniversityUnknown
-
University of Texas Southwestern Medical CenterCompleted
-
Rajavithi HospitalCompletedTo Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk WomenThailand